7462-84-2 Usage
General Description
1-methylpiperidine-4-carbonyl chloride hydrochloride is a chemical compound with the molecular formula C8H15Cl2NO. It is a hydrochloride salt of 1-methylpiperidine-4-carbonyl chloride, which is commonly used in organic synthesis as a reagent for the preparation of various compounds. 1-methylpiperidine-4-carbonyl chloride hydrochloride is a derivative of piperidine, a heterocyclic amine, and is commonly used in the pharmaceutical industry for the synthesis of various drugs. It is a white crystalline solid with a melting point of around 95-98°C and is soluble in water and in most organic solvents. 1-methylpiperidine-4-carbonyl chloride hydrochloride is an important intermediate in the production of various pharmaceuticals and is used in research and development in the pharmaceutical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 7462-84-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,4,6 and 2 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 7462-84:
(6*7)+(5*4)+(4*6)+(3*2)+(2*8)+(1*4)=112
112 % 10 = 2
So 7462-84-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H12ClNO/c1-9-4-2-6(3-5-9)7(8)10/h6H,2-5H2,1H3
7462-84-2Relevant articles and documents
SUBSTITUTED 5-(PYRAZIN-2-YL)-1H-PYRAZOLO [3,4-B] PYRIDINE AND PYRAZOLO [3,4-B] PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS
-
Page/Page column 30, (2012/10/18)
Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3,4-b] pyridine, 5-(pyrazin-2-yl)-1H-pyrrolo[2,3-b]pyridine and pyrazolo [3,4-b] pyridine derivatives according to formula I, II and VII, and methods for making same, which are inhibitors of constitutively activated Tyrosine Kinase-Like (TKL), CMGC protein kinases family members and can be useful in the treatment of Parkinson?s disease, Alzheimer?s disease, Down?s Syndrome, Huntington?s disease, other neurodegenerative and central nervous system disorders, cancer, metabolic disorders and inflammatory diseases. Also disclosed are pharmaceutical compositions including the compounds and methods of inhibiting wild type and/or mutated protein kinase activities of these families and the treatment of disorders associated there with using compounds and pharmaceutical compositions including the compounds.
